Form 4 for SRPT Sarepta Therapeutics, Inc.

Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0000950170-24-026607 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-03-05	2024-03-01	SRPT	Rodino-Klapac Louise	CSO, Head of R, D	A - Grant	$0.00	+6,000	71.2K	+9%	$0
D	2024-03-05	2024-03-01	SRPT	Rodino-Klapac Louise	CSO, Head of R, D	F - Tax	$126.19	-778	65.2K	-1%	-$98.2K
D	2024-03-05	2024-03-01	SRPT	Rodino-Klapac Louise	CSO, Head of R, D	A - Grant	$0.00	+12.5K	12.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-03-01	A	A	6,000	$0.00	71,222	D	—	—	(F3) The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
2	Common	Common Stock	2024-03-01	F	D	778	$126.19	65,222	D	—	—	(F1) Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020. (F2) Amount of Securities Beneficially Owned includes 249 shares purchased under the Company's registered Employee Stock Purchase Plan on February 29, 2024.
3	Derivative	Stock Option (right to buy)	2024-03-01	A	A	12,500	$0.00	12,500	D	$128.67 · 2025-03-01 to 2034-03-01	12,500 Common Stock	(F4) Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.